Jonas Ecker
Heidelberg, BW, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 39 publications
Advancing CNS tumor diagnostics with expanded DNA methylation-based classification.
Journal: Cancer cell
Published: May 06, 2025
Constitutional variants in PTEN: a frequent finding in patients with papillary tumors of the pineal region subtype B (PTPR-B) associated with isolated loss of chromosome 10.
Journal: Acta neuropathologica
Published: January 26, 2025
Association of phosphorylation status of ERK and genetic MAPK alterations in pediatric tumors.
Journal: Scientific reports
Published: January 08, 2025
Combination drug screen identifies synergistic drug interaction of BCL-XL and class I histone deacetylase inhibitors in MYC-amplified medulloblastoma cells.
Journal: Journal of neuro-oncology
Published: November 01, 2023
Generation of patient-derived pediatric pilocytic astrocytoma in-vitro models using SV40 large T: evaluation of a modeling workflow.
Journal: Journal of neuro-oncology
Published: September 27, 2023
Class I HDAC inhibition reduces DNA damage repair capacity of MYC-amplified medulloblastoma cells.
Journal: Journal of neuro-oncology
Published: August 04, 2023
Clinical outcome of pediatric medulloblastoma patients with Li-Fraumeni syndrome.
Journal: Neuro-oncology
Published: June 28, 2023
Corrigendum to 'Molecular diagnostics enables detection of actionable targets: the Pediatric Targeted Therapy 2.0 registry' [Eur J Cancer 180 (2023) 71-84].
Journal: European journal of cancer (Oxford, England : 1990)
Published: March 23, 2023
Class I HDAC inhibitor entinostat synergizes with PLK1 inhibitors in MYC-amplified medulloblastoma cells.
Journal: Journal of neuro-oncology
Published: March 21, 2023
Key Pharmacokinetic Parameters of 74 Pediatric Anticancer Drugs Providing Assistance in Preclinical Studies.
Journal: Clinical pharmacology and therapeutics
Published: March 03, 2023
Correction to: Amplification of the PLAG-family genes-PLAGL1 and PLAGL2-is a key feature of the novel tumor type CNS embryonal tumor with PLAGL amplification.
Journal: Acta neuropathologica
Published: February 14, 2023
Glioneuronal tumor with ATRX alteration, kinase fusion and anaplastic features (GTAKA): a molecularly distinct brain tumor type with recurrent NTRK gene fusions.
Journal: Acta neuropathologica
Published: January 04, 2023
Last Updated: 09/26/2026